Yamaue R, Torikai M, Terashima M, Mori H
Vaccines (Basel). 2024; 12(7).
PMID: 39066391
PMC: 11281633.
DOI: 10.3390/vaccines12070753.
Bergeron H, Tripp R
Viruses. 2021; 13(12).
PMID: 34960746
PMC: 8703574.
DOI: 10.3390/v13122478.
Descamps D, Peres de Oliveira A, Gonnin L, Madrieres S, Fix J, Drajac C
J Virol. 2021; 95(22):e0091221.
PMID: 34431698
PMC: 8549506.
DOI: 10.1128/JVI.00912-21.
Drajac C, Laubreton D, Marquant Q, Chottin C, Ferret C, Bouguyon E
Mucosal Immunol. 2021; 14(4):949-962.
PMID: 33846534
PMC: 8221999.
DOI: 10.1038/s41385-021-00402-w.
Shilovskiy I, Yumashev K, Nikolsky A, Vishnyakova L, Khaitov M
Biochemistry (Mosc). 2021; 86(3):290-306.
PMID: 33838630
PMC: 7957450.
DOI: 10.1134/S0006297921030068.
Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition.
Ko E, Lee Y, Lee Y, Hwang H, Park Y, Kim K
Immune Netw. 2021; 20(6):e51.
PMID: 33425436
PMC: 7779866.
DOI: 10.4110/in.2020.20.e51.
Priorities for developing respiratory syncytial virus vaccines in different target populations.
Drysdale S, Barr R, Rollier C, Green C, Pollard A, Sande C
Sci Transl Med. 2020; 12(535).
PMID: 32188721
PMC: 7613568.
DOI: 10.1126/scitranslmed.aax2466.
Pathogenesis of Respiratory Syncytial Virus Infection in BALB/c Mice Differs Between Intratracheal and Intranasal Inoculation.
van Erp E, Lakerveld A, Mulder H, Luytjes W, Ferwerda G, van Kasteren P
Viruses. 2019; 11(6).
PMID: 31163619
PMC: 6631102.
DOI: 10.3390/v11060508.
Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.
Schmidt M, Oomens A, Varga S
J Immunol. 2019; 202(11):3234-3245.
PMID: 31004010
PMC: 6529240.
DOI: 10.4049/jimmunol.1900050.
Small Animal Models of Respiratory Viral Infection Related to Asthma.
Han M, Rajput C, Ishikawa T, Jarman C, Lee J, Hershenson M
Viruses. 2018; 10(12).
PMID: 30513770
PMC: 6316391.
DOI: 10.3390/v10120682.
Transcriptomics in lung tissue upon respiratory syncytial virus infection reveals aging as important modulator of immune activation and matrix maintenance.
Pennings J, Mariman R, Hodemaekers H, Reemers S, Janssen R, Guichelaar T
Sci Rep. 2018; 8(1):16653.
PMID: 30413794
PMC: 6226529.
DOI: 10.1038/s41598-018-35180-2.
Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.
Boukhvalova M, Yim K, Blanco J
Antivir Chem Chemother. 2018; 26:2040206618770518.
PMID: 29768937
PMC: 5987903.
DOI: 10.1177/2040206618770518.
Animal models of respiratory syncytial virus infection.
Taylor G
Vaccine. 2016; 35(3):469-480.
PMID: 27908639
PMC: 5244256.
DOI: 10.1016/j.vaccine.2016.11.054.
Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.
High M, Cho H, Marzec J, Wiltshire T, Verhein K, Caballero M
EBioMedicine. 2016; 11:73-84.
PMID: 27554839
PMC: 5049919.
DOI: 10.1016/j.ebiom.2016.08.011.
Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
Currie S, Gwyer Findlay E, McFarlane A, Fitch P, Bottcher B, Colegrave N
J Immunol. 2016; 196(6):2699-710.
PMID: 26873992
PMC: 4777919.
DOI: 10.4049/jimmunol.1502478.
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.
Acosta P, Caballero M, Polack F
Clin Vaccine Immunol. 2015; 23(3):189-95.
PMID: 26677198
PMC: 4783420.
DOI: 10.1128/CVI.00609-15.
Visualizing the replication of respiratory syncytial virus in cells and in living mice.
Rameix-Welti M, Le Goffic R, Herve P, Sourimant J, Remot A, Riffault S
Nat Commun. 2014; 5:5104.
PMID: 25277263
PMC: 7091779.
DOI: 10.1038/ncomms6104.
An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.
Cherukuri A, Stokes K, Patton K, Kuo H, Sakamoto K, Lambert S
Immun Ageing. 2012; 9(1):21.
PMID: 23031690
PMC: 3534329.
DOI: 10.1186/1742-4933-9-21.
Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.
Schijf M, Kruijsen D, Bastiaans J, Coenjaerts F, Garssen J, van Bleek G
J Virol. 2012; 86(21):11472-82.
PMID: 22896622
PMC: 3486291.
DOI: 10.1128/JVI.06708-11.
Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.
Johnson C, Miao C, Blanchard E, Caidi H, Radu G, Harcourt J
Comp Med. 2012; 62(1):14-20.
PMID: 22330646
PMC: 3276387.